Michael Rossi has been named the new CEO of Y-mAbs Therapeutics
New York, NY, October 18, 2023 (Globe Newswire) -- Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) has named Michael Rossi as President and CEO, effective November 6, 2023. Rossi will also join the company's Board of Directors. Y-mAbs focuses on developing and commercializing antibody-based therapeutic products for cancer treatment.
Read full article here.